Pinnacle Financial Group, Inc.’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.11K Buy
+300
New +$7.48K ﹤0.01% 1701

Other funds holding NRIX

Pinnacle Financial Group, Inc.'s NRIX Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Nurix Therapeutics (NRIX) in Q3 2026: 300 shares worth $7.11K. The stake represents ﹤0.01% of the portfolio and ranks #1701 among its holdings.

234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 300 shares of Nurix Therapeutics worth $7.11K as of Q3 2026.
  • Nurix Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Nurix Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1701 holding.
  • 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.